Fundraising Fox
Synakis Corp.
Toronto, CA · 2 known investors
Find your way into Synakis Corp.
Sign up to see every warm intro you have to Synakis Corp.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Synakis Corp. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Synakis develops ocular biomaterials, including its lead candidate SNK-125, through pre-clinical research and a pipeline of eye-related products. The company operates in the ophthalmic biomaterial and biotech space.
Founders & leadership
TN
Thierry NivaggioliCEOThierry Nivaggioli is a biotech executive with over 25 years in ophthalmology, drug delivery, and biomaterials, and currently serves as CEO of Synakis, which develops ocular biomaterial platforms for retinal surgery and long-acting drug delivery systems targeting glaucoma and retinal diseases.
Investors · 2
Ontario Centre of Innovationlisted by Ontario Centre of InnovationToronto · $500K
How we know: Ontario Centre of Innovation's portfolio page · Not right? Tell us
Frequently asked questions
- What does Synakis Corp. do?
- Synakis develops ocular biomaterials, including its lead candidate SNK-125, through pre-clinical research and a pipeline of eye-related products. The company operates in the ophthalmic biomaterial and biotech space.
- Who are Synakis Corp.'s investors?
- Synakis Corp.'s investors include Ontario Centre of Innovation, Ontario Centre of Innovation programs.
- Where is Synakis Corp. headquartered?
- Synakis Corp. is headquartered in Toronto, CA.